Spectrum Pharmaceuticals Top Insiders
Spectrum Pharmaceuticals employs about 86 people. The company is managed by 7 executives with a total tenure of roughly 9 years, averaging almost 1.0 years of service per executive, having 12.29 employees per reported executive. Assessment of Spectrum Pharmaceuticals' management performance can provide insight into the firm performance.
| Thomas Riga CEO CEO Pres |
Spectrum |
Spectrum Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.3821) % which means that it has lost $0.3821 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.6502) %, meaning that it created substantial loss on money invested by shareholders. Spectrum Pharmaceuticals' management efficiency ratios could be used to measure how well Spectrum Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Spectrum Pharmaceuticals Workforce Comparison
Spectrum Pharmaceuticals is rated third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,323. Spectrum Pharmaceuticals holds roughly 86.0 in number of employees claiming about 7% of equities under Health Care industry.
The company has Profit Margin (PM) of (2.52) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.47. Spectrum Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Spectrum Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Spectrum Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Spectrum Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Vacirca Jeff L over a year ago Disposition of 295244 shares by Vacirca Jeff L of Spectrum Pharmaceuticals subject to Rule 16b-3 | ||
Dolatrai Vyas over a year ago Acquisition by Dolatrai Vyas of 20000 shares of Spectrum Pharmaceuticals subject to Rule 16b-3 |
Spectrum Pharmaceuticals Notable Stakeholders
A Spectrum Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Spectrum Pharmaceuticals often face trade-offs trying to please all of them. Spectrum Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Spectrum Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Thomas Riga | CEO Pres | Profile | |
| MD MBA | VP Devel | Profile | |
| Michael Grabow | Exec Officer | Profile | |
| Bimal Shah | VP Devel | Profile | |
| Nora Brennan | Ex Officer | Profile | |
| LLM JD | Chief VP | Profile | |
| MD FRCPC | Ex Officer | Profile |
Spectrum Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Spectrum Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Spectrum Pharmaceuticals within its industry.Spectrum Pharmaceuticals Manpower Efficiency
Return on Spectrum Pharmaceuticals Manpower
| Revenue Per Employee | 117.6K | |
| Revenue Per Executive | 1.4M | |
| Net Loss Per Employee | 876.8K | |
| Net Loss Per Executive | 10.8M | |
| Working Capital Per Employee | 678.2K | |
| Working Capital Per Executive | 8.3M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Spectrum Stock
If you are still planning to invest in Spectrum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spectrum Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |